Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics Pharmaceutical Industry Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics admin June 8, 2026 0 Novo itself is beginning to generate data suggesting semaglutide may actually affect biological processes linked to aging,... Read More Read more about Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics
